Background. Recent epidemiological studies suggest that post-menopausal hormone replacement therapy might reduce the risk of hip osteoarthritis (OA) in women. However, the association of the disorder with other reproductive variables is controversial. We addressed this issue in a population-based case-control study among 413 female cases and 413 age-and sexmatched controls.
O (OA) is a common, often debilitating together had a combined population of~1 million residents. They were selected for the following reasons: disorder, which accounts for a substantial majority of (a) they each have a centralized orthopaedic facility the 30 000 total hip arthroplasties carried out each for the assessment and treatment of hip OA; (b) the year in England and Wales [1] . Epidemiological studies local orthopaedic surgeons were willing to enter all suggest differences in the incidence pattern with age in patients into the study; (c) they have a diverse sociothe two sexes: in women, incidence rates stabilize at economic profile with inclusion of both affluent and the age of 60 yr, while in men incidence rates continue deprived areas. to rise, often into the seventh or eighth decade. This
The detailed methods have been previously pubobservation has prompted investigators to suggest a lished [12] . In brief, a register was established in each role for oestrogen in the aetiology of OA. Case-control district whereby the orthopaedic surgeons recorded all and cohort studies suggest a protective effect of horwomen aged 45 yr and over who were placed on the mone replacement therapy (HRT ) [2] [3] [4] [5] [6] , but there waiting list for primary total hip arthroplasty over an have been relatively few studies examining the influence 18 month period. The medical records of each subject of other reproductive variables [7] [8] [9] [10] [11] , and results were reviewed, and the individual was excluded if she have often been inconsistent. We therefore examined had suffered a hip fracture within the preceding year, the relationship of HRT use, hysterectomy (with or fulfilled ACR criteria [13] for rheumatoid arthritis or without oophorectomy) and other reproductive varimodified New York criteria [14] for ankylosing sponables to symptomatic hip OA, as part of a populationdylitis, or had a history of Perthes' disease, congenital based case-control study.
hip Service Association. As almost everyone in the UK is Obesity, hip injury, leisure activity and Heberden's nodes have all been shown to be significant (P < 0.05) registered with a general practitioner, such lists essentially enumerate the population. Controls were risk factors for hip OA in this study [12] . Among the women included in this analysis, the risk in the highest excluded using the same criteria as cases, and controls who declined to participate were replaced.
third of the distribution of BMI was 1.6 (95% CI 1.1-2.3) when compared with the lowest third. After giving informed consent, cases and controls completed a structured interviewer-administered quesPrevious hip injury was associated with a 3-fold increase in the risk of hip OA (OR 3.0, 95% CI 1.5-6.1) tionnaire, enquiring about their medical history, lifestyle and leisure time activities. Information collected and those women participating in three or more physically active leisure pursuits during their youth also had on reproductive variables included age at menarche and menopause, number of pregnancies, age at hysteran increased risk of hip OA in later life (OR 1.6, 95% CI 1.0-2.5). ectomy (if applicable) and whether one or both ovaries had been removed at the time (if known). Each woman Eighty-one women (10%) had ever taken HRT, while only eight women (1%) were taking HRT at the was asked if she had ever taken HRT or oral contraceptives, and if so, for how long. Where required, time of their interview. In those women who had ever used HRT, 59 (74%) had taken it for <5 yr, nine information was validated by examination of general practice records. The questions about leisure activities (11%) had taken it for between 5 and 9 yr, and 12 (15%) had taken it for 10 yr or longer. A total of 21% covered participation in sports since leaving school, and the frequency and duration of other physically of women who had undergone oophorectomy had ever used HRT: 13% for <5 yr and 8% for >5 yr. In those active pursuits (walking, cycling, gardening and dancing). Subjects were asked whether they had ever women who reported both hip pain and HRT use (52 women), 19 had started HRT before the onset of pain, injured their hip badly enough to consult a doctor about it. Hip injuries were considered significant if while hip pain pre-dated HRT prescription in 32 individuals. The two events were simultaneous in one they resulted in an inability to weight bear for at least 1 week, and had occurred at least 1 yr before the onset woman. The median age at menarche of both the cases and their controls was 14 yr, and the median age at of hip pain. Measurements of body height and weight were made using portable scales and a stadiometer, menopause was 50 yr in both groups. Eighty-two women (10%) had used the oral contraceptive pill and and the hands of all subjects were examined for the presence of Heberden's nodes (a marker for constitu-100 (13%) had undergone an oophorectomy. In these women, the majority (63; 63%) had both ovaries tional predisposition to generalized OA).
The data were analysed by conditional logistic removed. The prevalence of previous hysterectomy was 21%. regression, and the results summarized as odds ratios (OR) with 95% confidence intervals (CI ). Odds ratios Table I shows the relationship between these reproductive variables and the risk of hip OA. After adjustare presented both unadjusted and adjusted for the presence of Heberden's nodes (absent/possible/definment for potential confounders and other reproductive variables, short-term (<5 yr) HRT use was associated ite), body mass index (BMI ) (in thirds of the distribution) and previous hip injury.
with an excess risk of hip OA (OR 1.7, 95% CI 0.9-3.3); longer term use showed a weak protective RESULTS effect (OR 0.6, 95% CI 0.2-1.8). When we divided the group according to whether HRT was started before We identified 579 women aged 45 yr and over who were consecutively listed for total hip arthroplasty in or after the onset of hip pain, a protective effect of short-term (<5 yr duration) HRT was demonstrated Portsmouth and North Staffordshire over the 18 month study period. A total of 472 fulfilled criteria for entry in women who had started HRT at the same time as, or before, hip pain began (OR 0.5, 95% CI 0.2-1.2), to the study as cases, the main reasons for exclusion being inflammatory arthritis (40 women) and residence while in women who commenced HRT after the onset of hip pain, a non-significant increased risk of OA was out of the area (52 women); 424 (90%) of the eligible cases agreed to participate. The two main problems again observed (OR 1.3, 95% CI 0.7-2.5). Long-term (>5 yr) HRT was protective in both groups (OR 0.5, with control recruitment were general practitioner refusal to allow their patient to be approached (13%), 95% CI 0.2-1.5 for women whose therapy pre-dated pain; OR 0.2, 95% CI 0.0-0.8 for women starting longand refusal by the women themselves (28%). Thirteen women from 11 matched pairs were pre-menopausal term therapy after the onset of hip pain). The risk of hip OA was increased in women who had undergone and these pairs were excluded from the analysis. This report is based on the remaining 413 case-control pairs oophorectomy (OR 1.9, 95% CI 1.0-3.7). Age at menarche, age at menopause and number of pregnanwho provided complete information on the main risk factors under study.
cies were not significantly associated with risk of hip OA. The ages of the cases ranged from 66.2 to 77.3 yr with a median of 72.4 yr. The minimum joint space on DISCUSSION plain radiography was ∏1.5 mm in 86% of the case series, and 95% had at least grade 3 osteoarthritic
We have demonstrated that surgical oophorectomy is associated with an increased risk of symptomatic change, according to the Kellgren and Lawrence grading system. hip OA. In addition, our results accord with those of previous studies, in showing that long-term HRT use therefore we would expect any errors to obscure rather than exaggerate associations with OA. is associated with a reduced risk of the disease. Shortterm use of HRT, however, was associated with an Earlier data relating oophorectomy and hysterectomy to the risk of symptomatic OA are inconsistent, increased risk of OA, which may reflect the prescription of HRT to women who present with hip pain. Other and may reflect differences in the relationship of these factors to OA at different sites. In the first study to risk factors included high BMI, high level of leisure physical activity and previous hip injury, but adjustaddress this issue, an excess rate of surgical menopause was found among women with knee and hip OA ment of the risks associated with surgical oophorectomy and HRT for these other factors did not alter attending hospital out-patient departments, when compared with women attending hospital for other reasons them appreciably.
Our study has certain limitations. This is a study of [7] . The Study of Osteoporotic Fractures [10] revealed a protective effect of oophorectomy against hip OA, end-stage hip OA among women referred for total hip replacement. If women seeking medical care (and which the investigators felt was most probably explained by increased rates and longer term use of hence receiving hip replacement) were also more likely to take HRT, we might have detected a spurious HRT among those women who had undergone surgical menopause. In another cohort study, an excess risk of positive association of HRT with end-stage hip OA. Alternatively, it is possible that HRT might have been OA of the knee and thumb-base was reported among women who had undergone hysterectomy [8] ; no addmore frequently prescribed to women having hip pain, a possibility supported by our observation that 62% itional risk of OA was found in the small group of women who had undergone hysterectomy and oophorreported HRT use starting after the onset of hip pain. The prevalence of post-menopausal oestrogen use was ectomy, rather than hysterectomy alone. By contrast, data from a cohort of 831 women aged 73 yr, resident relatively low, with a corresponding constraint on statistical power. However, these figures accord with in Framingham, indicated no difference in age at menopause or rate of hysterectomy among groups, estimates that HRT is ever used by 15% of eligible UK women, and used for more than a few years in defined by the presence or severity of OA [3] . Similarly, the Baltimore Longitudinal Study of Ageing [11] found only 5% [17] . In particular, HRT use in women who had undergone oophorectomy was surprisingly low; no significant difference in the frequency of hysterectomy in those with or without knee OA. previous surveys have suggested a prescription rate of 30% for any duration of HRT use [18] . We were Data are more consistent in pointing to a protective effect of HRT on the risk of OA. Among women in unable to validate subjects' reports of oophorectomy at the time of hysterectomy, although in this age group
Framingham who had ever used HRT, there was a 30% reduction in the risk of radiographic knee OA it is more likely that oophorectomy had occurred without the subject being aware, than the reverse. We [3] . As in our study, there was also an excess risk of knee OA among those women who had used HRT have no reason, however, to suspect that the accuracy of information about HRT use and oophorectomy short term (<1 yr), although this was non-significant. Four other studies have suggested that HRT might differed systematically between cases and controls, and total knee replacement. Bristol: Bristol Health Care protect against the initiation or progression of OA at Evaluation Unit, University of Bristol, 1992. the hip or knee [4] [5] [6] 19] . In the largest of these, or bone metabolism. Oestrogen receptors are found in
